Yonsei University
- Country
- 🇰🇷South Korea
- Ownership
- Private
- Established
- 1885-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.yonsei.ac.kr
Pembrolizumab in Combination With Paclitaxel in the Hormone Receptor-positive Metastatic Breast Cancer With High Tumor Mutational Burden Selected by Whole Exome Sequencing: Korean Cancer Study Group Trial (KCSG BR20-16)
- First Posted Date
- 2018-04-10
- Last Posted Date
- 2022-03-15
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 30
- Registration Number
- NCT03492918
- Locations
- 🇰🇷
Yonsei Cancer Center at Yonsei University Health System, Seoul, Korea, Republic of
K-Basket, Avelumab, Biomarker-driven, Advanced Solid Tumor
- Conditions
- PD-L1 Positive Mutation TumorMSI-H Mutation TumorEBV Positive Mutation TumorPOLE/POLD1 Mutation Tumor
- Interventions
- First Posted Date
- 2018-04-09
- Last Posted Date
- 2022-08-09
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 60
- Registration Number
- NCT03491345
- Locations
- 🇰🇷
Division of Medical Oncology, Severance Breast Cancer Clinic, Yonsei Cancer Center, Severance Hospital, Yonsei University Health System, Seoul, Korea, Republic of
Effect of Heated Breathing Circuit on Intraoperative Core Temperature and Systemic Inflammation After Brain Surgery: a Prospective Randomized Study
- Conditions
- Patients Scheduled for Brain Surgery
- Interventions
- Device: conventional circuitDevice: new humidifaction heat circuitDevice: conventional humidification circuit
- First Posted Date
- 2018-04-09
- Last Posted Date
- 2019-03-18
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 117
- Registration Number
- NCT03491332
- Locations
- 🇰🇷
Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institue, Yonsei Universiy College of Medicine, Seoul, Korea, Republic of
Rivaroxaban Once Daily Versus Dose-adjusted Vitamin K Antagonist on the Biomarkers in Acute Decompensated Heart Failure and Atrial Fibrillation (ROAD HF-AF)
- First Posted Date
- 2018-04-06
- Last Posted Date
- 2019-01-10
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 150
- Registration Number
- NCT03490994
- Locations
- 🇰🇷
Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea, Republic of
Genomic Profiling of the Residual Disease of Advanced-stage Ovarian Cancer After Neoadjuvant Chemotherapy
- Conditions
- Advanced-stage Ovarian Cancer
- Interventions
- Drug: chemotherapy
- First Posted Date
- 2018-04-06
- Last Posted Date
- 2018-04-10
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 250
- Registration Number
- NCT03491033
- Locations
- 🇰🇷
Severance hospital, Seoul, Korea, Republic of
Effects of Statin on Hepatocellular Carcinoma Recurrence After Liver Transplantation
- First Posted Date
- 2018-04-06
- Last Posted Date
- 2018-04-06
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 350
- Registration Number
- NCT03490461
- Locations
- 🇰🇷
Division of Endocrinology and Metabolism Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea, Republic of
A Study for Identification of Predictive Immune Biomarker in Peripheral Blood for Nivolumab Therapy in NSCLC Patients
- Conditions
- Non -Small Cell Lung Cancer
- First Posted Date
- 2018-04-03
- Last Posted Date
- 2020-10-19
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 60
- Registration Number
- NCT03486119
- Locations
- 🇰🇷
Department of Oncology, Yonsei University College of Medicine, Seoul, Korea, Korea, Republic of
Assessment and Prediction of Cetuximab-Induced Hypersensitivity Reactions Using Cetuximab Specific IgE Detection
- Conditions
- Tumor Disease Including Colorectal CancerHead & Neck Squamous Cell Carcinoma
- First Posted Date
- 2018-04-02
- Last Posted Date
- 2019-04-02
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 400
- Registration Number
- NCT03485638
- Locations
- 🇰🇷
Division of Allergy and Immunology, Department of Internal Medicine, Yonsei University, Seoul, Korea, Republic of
Prediction of Benefit From Adjuvant Chemotherapy for pT1N1 Gastric Cancer
- Conditions
- Gastric Cancer
- First Posted Date
- 2018-04-02
- Last Posted Date
- 2018-04-09
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 1000
- Registration Number
- NCT03485105
- Locations
- 🇰🇷
Division of Upper Gastrointestinal Surgery, Department of Surgery, Yonsei University College of Medicine, Seoul, Korea, Republic of
Effect of Immunosuppression in IgA Nephropathy
- Conditions
- Biopsy-proven IgA Nephropathy
- Interventions
- Drug: Immunosuppressive treatmentOther: intensive supportive care
- First Posted Date
- 2018-03-19
- Last Posted Date
- 2019-02-08
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 174
- Registration Number
- NCT03468972
- Locations
- 🇰🇷
Severance Hospital, Seoul, Korea, Republic of